Table 1 Demographic and clinical characteristics of children empirically treated for TB at Mulago Pediatric TB unit (N = 516)*
From: Outcomes of empiric treatment for pediatric tuberculosis, Kampala, Uganda, 2010–2015
Characteristic | Favorable (N = 422) | Unfavorable (N = 94) | p-value† |
|---|---|---|---|
N (%, 95 CI) | N (%, 95 CI) | ||
Age group | |||
< 5 years | 280 (66, 62–71) | 57 (61,50–70) | 0.006 |
5–9 years | 104 (25, 21–29) | 18 (19, 12–28) | |
10–14 years | 38 (9, 7–12) | 19 (20, 13–30) | |
Male Sex | 238 (56, 52–61) | 48 (51, 41–61) | 0.35 |
Reside outside of Kampala | 174 (41, 37–46) | 62 (66, 56–75) | < 0.001 |
Pulmonary TB (n = 515) | 291 (69, 65–73) | 53 (67, 57–76) | 0.69 |
HIV positive (n = 509) | 19 (5, 3–7) | 12 (14, 8–23) | 0.001 |
Severe Malnutrition‡ (n = 349) | 60 (20, 16–25) | 16 (32, 20–46) | 0.06 |
Hospitalized (n = 480) | 33 (8, 6–11) | 26 (34, 24–45) | < 0.001 |
Abnormal Chest X-ray (n = 367) | 297 (93, 90–96) | 46 (94, 82–98) | 1.0 |
BCG vaccinated (n = 301) | 239 (92, 88–95) | 35 (83, 68–92) | 0.06 |
Baseline Hepatomegaly (n = 383) | 28 (8, 6–12) | 13 (30, 18–46) | < 0.001 |
TST Positive (n = 246) | 161 (75, 69–80) | 18 (58, 40–74) | 0.05 |